estimated GFR

Related by string. * esti mated . estimating . ESTIMATED . Estimating . Estimated . ESTIMATING : Estimated ticket sales . estimated #.#mn b [002] . estimated #.#mn b [001] . BASIS Estimated Actual . estimated metallurgical recoveries . Revenue Estimating Conference . estimated glomerular filtration . Estimated completion . estimating quantities . Closing Estimated Volumes / : GFR * *

Related by context. Frequent words. (Click for all words.) 73 eGFR 70 estimated glomerular filtration 69 glomerular filtration rate 67 HbA1C 65 microalbuminuria 65 creatinine levels 64 univariate 64 glycated hemoglobin 64 multivariate analyzes 63 creatinine clearance 63 cystatin C 62 carotid intima media 62 serum calcium 62 HbA 1c 62 serum concentrations 62 HbA1c levels 61 hemoglobin A1C 61 MetS 61 serum creatinine 61 creatinine 61 serum PSA 61 serum uric acid 61 univariate analysis 60 CI -#.# 60 logistic regression 60 comorbid conditions 60 echocardiographic 60 fasting plasma glucose 60 glargine 60 Lp PLA2 59 % CI #.#-#.# [006] 59 RECIST criteria 59 confidence interval #.#-#.# 59 antihypertensive medications 59 DAS# [002] 59 FDG PET 59 oral glucose tolerance 59 NGAL 59 hemoglobin A1c 59 irbesartan 59 D dimer 59 sensitivity specificity 59 hypoglycemic events 59 elevated CRP 59 immunohistochemical 59 glycosylated hemoglobin 59 lipid lowering drugs 59 HbA1c 59 impaired fasting glucose 58 Natalizumab 58 fasting glucose 58 ml min 58 serum sodium 58 Unified Parkinson Disease 58 Thrombolysis 58 surrogate endpoint 58 ADAS cog 58 HSCT 58 statistically significant p = 58 NT proBNP 58 glycemia 58 nomogram 58 systolic BP 58 tolvaptan 58 fasting insulin 57 pg mL 57 hs CRP 57 therapeutic regimens 57 QTc 57 ng dL 57 mmol L 57 A1c 57 T2DM 57 serum phosphorus 57 A1C levels 57 RECIST 57 hemoglobin concentration 57 KRAS mutations 57 proteinuria 57 hyperglycaemia 57 μg kg 57 IPSS 57 annualized relapse 57 pg ml 57 ziprasidone 57 nmol L 57 ANOVA 57 nonsignificant 57 Arch Intern Med 57 Ann Intern Med 57 subgroup analyzes 57 eszopiclone 57 achieved statistical significance 57 Solid Tumors 57 albuminuria 57 virologic failure 57 thyroxine 57 left ventricular dysfunction 57 coronary revascularization 57 pharmacodynamic effects 56 fasting glucose levels

Back to home page